Cardiovascular health, heart failure, atherosclerosis, and cardiac research
460 articles
New evidence suggests oral semaglutide sustains long-term improvements in key CVD risk factors, expanding its role beyond diabetes management.
A landmark AHA statement challenges decades of blanket activity restrictions for children with cardiomyopathy, offering new risk-stratified guidance.
Isoquercitrin reshapes gut bacteria and tryptophan metabolism to reduce arterial plaque, pointing to a novel gut-heart therapeutic pathway.
A sirtuin enzyme prevents heart scarring by keeping cardiac fibroblasts from switching to a pro-fibrotic metabolic state.
A landmark review maps how computational heart models can decode diabetic cardiomyopathy and predict responses to SGLT2i and GLP-1 drugs.
Researchers defend their findings on screening-detected atrial fibrillation and cardiovascular outcomes in younger adults.
Columbia cardiologists describe an unusual mechanical cause of congestive heart failure where impaired ventricular filling is the central culprit.
A novel TRPM7-zinc pyroptosis pathway may explain why heart tissue dies during ischemia-reperfusion injury.
Yale researchers map the neurocardiac axis, revealing how autonomic dysfunction drives major cardiovascular diseases and pointing to new neural therapies.
New research reveals how gut barrier breakdown activates cardiac JNK2, driving age-related atrial fibrillation through inflammation.
A multiregistry study of 587 pediatric HCM patients finds massive LVH dramatically raises arrhythmia and mortality risk, especially in young children.
A new mechanism linking LMNA mutations to cardiac arrhythmias and dysfunction in Emery-Dreifuss muscular dystrophy points to promising drug targets.
